Biomass is widely used for fuel in developing countries. Particles and gases of biomass burning may cause changes in the lung. In this prospective study we investigated histopathological changes in the lungs of 42 non-smoking women [mean age (59±10) years] caused by biomass smoke. We valuated exposure to biomass smoke, case histories, and the fi ndings of physical examination, radiology, bronchoscopy, and lung histopathology. Mean exposure to biomass smoke was (28±9) hour-year (1 hour-year equals 365 hours of exposure per year with average exposure of 1 hour a day). The radiological fi ndings were mass (42 %), reticulonodular opacities (31 %), mediastinal lymphadenopathy (26 %), pleuro-parenchymal fi brotic banding (19 %), widening of the pulmonary artery (14 %), ground glass (11 %), mosaic perfusion (9 %), consolidation (9 %), segmental or subsegmental atelectasis (7 %), and bronchiectasis (7 %). The patients were diagnosed with lung cancer (35 %), interstitial lung disease (31 %), sarcoidosis (9 %), tuberculosis (9 %), chronic obstructive pulmonary disease (4 %), chronic bronchitis (9 %), and metastasis (4 %). Bronchoscopy showed pilies, oedema, erythema, bronchus narrowing, endobronchial tumour, mucosal irregularity, increased vascularisation, blue-black anthracotic plaques, mucosal oedema, and purulent secretion. Transbronchial biopsies revealed neutrophil and lymphocyte leucocytes in the perivascular, peribronchiolar, and interalveolar septa, slightly enlarged connective tissue, thickening of the basal membrane, thickening of interalveolar septa, intimal and medial thickening of the vascular wall and vascular lumen narrowing, anthracosis between the cells and in the bronchiole epithelium. These fi ndings confi rm that biomass smoke has important toxic effects on the lung parenchyma, interstitium, and pulmonary vessels that may result in malignancies.
Heat releasing sources composed of biological material are called biomass'. Burning biomass and poor indoor air exchange may cause chronic lung diseases, interstitial lung disease, and cancer. The use of biomass in Turkey is common due to social, economic, and cultural reasons.
The most important aetiological factor in biomassrelated disease is the pollutant being released (1) (2) (3) . In suburban areas of Turkey women who make fi re, bake, and cook with biomass primarily composed of cowpat are exposed to its smoke. that may contain harmful pollutants such as aldehydes, phenols, and toluene (4, 5) . Incomplete burning of animal waste also releases CO, NO 2 , and SO 2 (5) . Exposure in this population, who are poor and have little access to healthcare services, is often associated with chronic lung damage and respiratory infections.
Our earlier experimental study (6) showed histopathological changes in the trachea and the lungs of rats exposed to biomass smoke for one hour a day for three, six, and nine months. Histopathological findings included lymphocyte, eosinophil, and macrophage infi ltrations in the interstitium, small papillary structures in the airway mucosa, thickening of the intimae and media of the pulmonary vessels, narrowing of pulmonary vessel lumens, and papillary adenomatous proliferation of the mucosa (6) .
The aim of this study was to determine if similar changes occurred in human lungs after biomass smoke exposure. The number of studies which include bronchoscopy in people exposed to biomass smoke is very small and we hoped to fi ll in this gap by analysing histopathological fi ndings in transbronchial tissue samples from women who had bronchoscopy performed and who were exposed to biomass smoke.
MATERIALS AND METHODS
This prospective study was approved by bioethics committees of the Yuzuncu Yil University Faculty of Medicine, and observed the Declaration of Helsinki. It was carried out between January 2007 and September 2009 in 42 women who had pathological fi ndings on lung roentgenograms. The women were exposed to biomass smoke for various hour-years (1 hour-year equals 365 hours of exposure per year with average exposure of 1 hour a day). Biomass exposure in the absence of other pollutant exposure is rare in men, and we excluded male patients from the study. Women who smoked tobacco and were exposed to biomass smoke were also excluded from the study. All of the patients lived in the countryside, which excludes an infl uence of metropolitan atmospheric air pollution to a reasonable extent.
Cigarette smoking and biomass exposure were determined by interview. The length of exposure to biomass smoke was expressed in years and the density of exposure in hours per day. Total exposure is therefore expressed in hour-years.
Posterior-anterior lung roentgenograms and fi ndings of computed tomography (CT) scans were analysed to confi rm that the patients met our inclusion criteria.
Bronchoscopy was performed in all of the patients included in the study according to our diagnostic algorithm. All patients signed an informed consent form before the procedure. They were also tested for platelet count, prothrombin time, and partial thromboplastin time. The patients underwent bronchoscopy after a four-hour fast and remained in the same operation room with resuscitation equipment ready throughout the procedure. Those experiencing a bronchospasm received a bronchodilator. For local anaesthesia they received an 8 mg kg -1 dose of 2 % lidocaine solution in spray. The nasal passageway was preferred for the use of fiberoptic bronchoscope (Olympus, Center Valley, PA, USA). Patients were monitored by pulse oximetry. Macroscopic fi nding were recorded. Transbronchial biopsy was collected from sub-lobe basal segments of patients with interstitial changes and common lesions, and from the lobes with limited lesions. Three hours after the transbronchial biopsy, a posterior-anterior lung roentgenogram was taken to exclude pneumothorax. Forceps biopsy was performed in patients with endobronchial lesions, and transbronchial needle aspiration biopsy in patients with mediastinal lymphadenopathy. Bacteriological and cytopathological analyses were performed on the bronchial lavage and biopsy samples. Anthracotic changes, infl ammatory infi ltration, thickening at alveolar septum, fi brosis, and malignancies were assessed by an experienced pathologist. Photos of histopathological samples were taken microscopically.
Continuous variables were expressed as mean ±standard deviation, while categorical variables were expressed as number and percentage. To determine the difference between the diagnostic groups in terms of continuous variables, we used the Mann-Whitney U test. To determine the relationships between the diagnostic groups and other categorical variables, we used the chi-square test and calculated the odds ratio. Statistical signifi cance was set at P<0.05. Data were processed using the SPSS (version 16) statistical software.
RESULTS
The age, biomass exposure, bronchoscopy fi ndings, and diagnosis for individual patients are shown in Table 1 . Average biomass exposure years and total Radiological fi ndings were as follows: mass (18 patients, 42.9 %); reticulonodular opacity (13 patients, 31 %); mediastinal lymphadenopathy (11 patients, 26.2 %); pleuroparenchymal fibrotic stripes (8 patients, 19 %); dilatation of the pulmonary artery (6 patients, 14.3 %); ground glass opacities (5 patients, 11.9 %); consolidation (4 patients, 9.5 %); mosaic perfusion (4 patients, 9.5 %); segmenter or subsegmenter atelectasis (3 patients, 7.1 %); and bronchiectasis (3 patients, 7.1 %).
Bleeding was seen in only one patient as a bronchoscopy complication and was controlled by lavage with a solution including adrenalin. Pneumothorax was not observed in any of the patients. The main fi ndings of bronchoscopy were indirect tumour findings such as oedema, erythema, and narrowing of the bronchus, indicating acute and chronic airway infl ammation. Findings of chronic bronchitis included swollen mucosa, purulent sputum, and dark blue or black anthracotic plates, generally in the upper lung lobes, and especially in the bifurcation regions. Direct tumour fi ndings included endobronchial neoplasm, mucous instability, and increased blood vessels.
We also performed bronchoscopic transbronchial biopsy (16 patients, 38 %); mucous biopsy (16 patients, 38 %); transcarinal needle aspiration biopsy (4 patients, 9.5 %); and bronchial lavage (6 patients, 14 %). Most of the patients had lung cancer and interstitial lung disease. Lung disease in these patients was diagnosed after more than 27 hours per year of biomass smoke exposure. However, one patient with 11 hours per year of biomass smoke exposure had a normal biopsy fi nding. The incision was performed to fi nd the cause of haemoptysis.
There was a highly negative correlation between interstitial lung disease and lung cancer (P=0.001). That biomass smoke exposure may cause different diseases in different people may partially be explained by a person's genetic predisposition to a disease. Table 2 shows the histopathological fi ndings in the patients with interstitial lung disease (ILD). Biopsy tissue of four patients was lost during examination.
Transbronchial biopsy taken from 16 of 21 patients who were thought to have ILD. Bronchial lavage was performed on five patients. Cytological analysis showed no malignant cells in these patients. Neutrophils were the dominant cell type for many patients. In one patient, lymphocytes accounted for 70 % of the cells. Tissue samples stained with haematoxylin and eosin (H&E) were examined under a light microscope (Olympus BX50F-3, Olympus Optical Co., Japan) at either 100x or 200x magnifi cation. Figure 1 shows the typical tissue samples obtained by bronchoscopy.
In the interalveolar septum, we observed perivascular and peribronchial neutrophils, lymphocytes, and alveolar macrophage infi ltration. In some cases this cell infi ltration let to the thickening of the interalveolar septa. In some patients, white blood cells infi ltrated the spaces around vessels, the intima and the media of the vessels thickened, and their lumens narrowed. Black coal dust in the form of granular debris or little piles were scattered between the cells. Similar piles were found in the bronchioles on the apical surface of the epithelium and in the intracytoplasmic space. In one patient, nodular fi brotic thickening was observed in some places. Bilateral and many nodular lesions, more obvious in the sub-lobes, were detected by lung tomography in one patient, who 
noted otherwise: (A) Anthracosis in the lung parenchyma with vascular wall thickening; (B) Basal membrane thickening, eosinophilic enhancement in bronchial mucosa (200x); (C) Infl ammatory focal thickening of alveolar septipara and lung parenchyma; (D) Dominated by lymphocytes, few neutrophils and plasma cells showing signs of chronic infl ammation of the bronchial mucosa
was thought to have ILD, but the bronchoscopic lavage histopathology did not support this diagnosis. However, a bulk was detected at the head of the pancreas in an abdomen tomography during examination of the patient, and the lung lesions were interpreted as metastasis.
Computer tomography detected a mass indicative of lung cancer in 14 patients, who then underwent bronchoscopy to confi rm or rule out this preliminary diagnosis. The following histopathological types of lung cancer were detected: small cell in six patients, squamous cell in two patients, adenocarcinoma in two patients, and bronchoalveolar carcinoma in one patient. In two patients, the malignant epithelial tumour could not be determined by the cell type, and the tumour in one patient was evaluated as benign.
Chronic infl ammation in a patient who complained of difficulty swallowing was followed up by endoscopy. Transbronchial biopsy revealed esophageal squamous carcinoma.
One of the four patients with mediastinal lymphadenopathy had right hilar lymphadenopathy and one had a consolidation at the right-mid lobe. The smear obtained by transcarinal thin needle aspiration biopsy did not show malignant cells. Patients diagnosed with sarcoidosis were introduced steroid treatment. All patients with lymphadenopathy showed a degree of regression due to treatment.
Tuberculosis was diagnosed in four patients. Mediastinal lymphadenopathy was established in one; a consolidation in the sub-lobe superior segment of the right lung in another; a consolidation in the sublobe of the right lung together with mediastinal lymphadenopathy in one patient; and a consolidation with fusion fi elds in the upper lobe of the right lung in one patient. Histopathological analysis showed a negative fi nding in the fi rst patient, an active chronic infl ammation in the second, chronic infl ammation in the third, and anthracosis in the fourth. Tuberculosis culture of bronchial lavage tested positive and all four patients were started antituberculosis treatment.
DISCUSSION
Exposure to biomass in buildings without proper ventilation increases the risk of acute airway infections in children and COPD, ILD, and lung cancer in the adults (2 ,3 ,7 ,8) . In Turkey, biomass smoke exposure is an important risk factor for lung diseases in nonsmoking women, especially in rural areas. However, tobacco smoke and biomass smoke-related lung diseases have similar characteristics.
Biomass smoke contains carbon monoxide, nitric acid, sulphur oxides, formaldehyde, polycyclic organic substances, carcinogens like benzopyrene, and particles smaller than 10 micrometers (9). Most of these components are mutagenic in vitro (9) . Smoke is an irritant toxic to cilia and contains coagulant agents which affect the respiratory system defence and increase the risk of chronic lung infection (10, 11) . Domestically-acquired particulate lung disease (DAPLD) is a term used to identify biomass-related lung diseases (12) . DAPLD manifests itself in a broad range of disorders from chronic bronchitis and COPD to advanced interstitial lung disease and malignancy.
Studies around the world have established a relationship between lung disease and exposure to biomass smoke. Pandey et al. (13) have shown that COPD prevalence rises with age and is greater Nepalese men than women (13). Akhtar et al. (9) identifi ed chronic bronchitis in 100 of 1426 Pakistani women burning biomass and established a strong relationship between bronchitis and biomass use compared to a control group. Demirtaş et al. (2) found that women who exposed to biomass smoke were signifi cantly more prone to COPD than unexposed women. Özbay et al. (1) detected a severe obstruction and an increase in the lung volume in pulmonary function tests of biomass-exposed women. They observed radiologically diffuse emphysema, thickening at interlobular septa, focal emphysematosa fi elds, and an increase in bronchovascular arborisation. They showed that biomass smoke increased obstructive and restrictive effects on the pulmonary function and structure. Our results seem to confirm the above studies, especially in reference to COPD. Sandaval et al. (14) have suggested that dense anthracotic staining is more characteristic of women exposed to biomass than of heavy tobacco smokers. Chung et al. (15) found anthracotic staining in people exposed to biomass smoke, in heavy smokers, miners, and city population. Bruce et al. (16) found that tuberculosis prevalence was higher in homes using biomass than in homes using cleaner combustibles. Similarly, Perez Podilla et al. (17) support the fi nding that heating with biomass at home contributes to tuberculosis. Shprykov et al. (18) found that tobacco smoke had a great effect on the structure of Mycobacterium tuberculosis. These structural changes suggest that smoke supports bacterial growth. In our study, in the four pulmonary tuberculosis diagnosed cases, dark anthracotic pigmentation and chronic infl ammation were detected that may have contributed to bacterial growth.
Biomass smoke contains numerous chemicals that are known or suspected human carcinogens. Mutations in human cancer are the most frequent in the p53 gene (19) . Mutation in the p53 gene is found in 50 % of non-small cell lung cancers and in 90 % of small cell lung cancers (20) .
Cigarette smoke contains almost 60 carcinogenic components including benz(a)pyrene (BaP) and nicotine-derived nitrosamine ketone (NNK), which induce p53 gene mutations (21) . Wood smoke contains BaP, just like cigarette smoke (16). Delgado et al. (3) detected mutation in the p53 gene in lung cancer cases related to wood smoke and in cancers caused by cigarette smoke. They proposed that, just like cigarette smoke, wood smoke can play a role in lung cancer. Malatz et al. (22) found higher frequency of genetic polymorphism in glutathione S-transferase enzymes in non-smoking lung cancer patients who were exposed to wood smoke for more than 20 years. In the regions of China in which lung cancer is common in humans, Liang et al. (23) investigated exposure to coal and wood smoke in mice and rats and found that wood smoke exposure involved a higher risk of cancer than control, but a lower risk compared to coal smoke exposed animals. Consistent with all these studies, our study has shown that biomass smoke exposure is an important risk factor for human lung cancer According to Gold et al. (24) , cooking may produce high levels of BaP that equal a packs of cigarettes a day. In another study (16) , BaP levels detected over three hours of cooking a day equalled two packs of cigarettes a day. These analogies help to explain how biomass smoke exposure can contribute to the growth of malignancy. Behera et al. (25) showed that adenocarcinoma was the dominant histopathological type of lung cancer in non-smoking women exposed to wood smoke. Similarly in Delgado et al. (3) , the main histopathological type was adenosarcoma in patients exposed to wood smoke (3). Hoffman et al. (26) showed that nicotine-derived nitrosamine ketone (NNK), contributed to adenocarcinoma and BaP to squamous cell carcinoma in lab animals. It is thought that wood smoke, like cigarette smoke, contains BaP, but it may also contain NNK and other carcinogens. In our patients, small cell carcinoma was the primary type of lung cancer, possibly due to a specific composition of the biomass.
Kajdaz et al. (27) found a signifi cant correlation between wood smoke exposure and sarcoidosis. In another study (28) wood burning and organic dust exposure had a signifi cantly higher correlation with sarcoidosis. In our study, four patients were diagnosed with sarcoidosis.
Chronic biomass smoke exposure changes the defense mechanisms of the lung mucociliary system and decreases the antibacterial capacity of macrophage (15, 29) . It may cause bronchial narrowing or blockage due to anthracosis or mucoid secretion piles at distal lung fields, and development of pneumonia at segments or lobes. Repeating infections increase bronchiectasis. Consistent with our study, Kara et al. (30) concluded that biomass smoke caused many diseases, from chronic bronchitis to interstitial lung disease.
Like in some of our patients, a transbronchial biopsy conducted in a patient exposed to wood smoke in India showed the existence of coal macules (31) . The main pathological changes in the transbronchial tissue samples of patients exposed to inorganic dust were similar to other interstitial lung diseases (32) (33) (34) . The samples showed focal thickening of the alveolar septum and a mix of infl ammatory infi ltration, fi brosis and basal membrane thickening. Restrepo et al. (35) found similar pathological fi brotis changes in animals and patients exposed to wood smoke for a long time. Ramage et al. (36) identifi ed a similar relationship between interstitial lung disease and wood smoke exposure. Our study has showed that exposure to biomass can cause histopathological lung lesions that range from the upper airway infl ammation to interstitial fibrosis and malignancy. These histopathological changes provide evidence of specific diseases attributable to biomass smoke exposure in nonsmoking women. One of the limitations of our study is that we have not established whether the exposed women were also exposed to secondary tobacco smoke.
